Detalhe da pesquisa
1.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
2.
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring.
Ann Hematol
; 102(11): 3133-3141, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480389
3.
Utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
Transpl Infect Dis
; 23(4): e13612, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825279
4.
Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction.
J Oncol Pharm Pract
; 26(1): 200-205, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760167
5.
The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.
Ann Hematol
; 98(3): 541-559, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666431
6.
Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
Cancer
; 125(21): 3890-3891, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291001
7.
Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase.
Leuk Lymphoma
; 63(11): 2663-2670, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699966
8.
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.
Blood Adv
; 6(21): 5750-5762, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640224
9.
Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.
Leuk Res
; 102: 106517, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33561633
10.
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.
Nat Med
; 27(12): 2192-2199, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873345